IDNNA
 | |
| Names | |
|---|---|
| IUPAC name
[2-(4-Iodo-2,5-dimethoxyphenyl)-1-methylethyl]dimethylamine | |
| Other names
2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(alpha-methyl)amine | |
| Identifiers | |
67707-78-2  | |
| ChEMBL | ChEMBL11043 |
| ChemSpider | 119009 |
| Jmol interactive 3D | Image |
| PubChem | 135056 |
| |
| |
| Properties | |
| C13H20NO2I | |
| Molar mass | 349.211 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is  ?) | |
| Infobox references | |
IDNNA, or 2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 2.6 mg, and the duration unknown. IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.
See also
External links
This article is issued from Wikipedia - version of the Tuesday, July 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.